Skip to content
Inciteful Med

Daily Life & Long-Term Monitoring: Staying Ahead

Last updated:

Managing scleroderma requires proactive monitoring of the lungs, heart, and kidneys, even when you feel well. Daily life involves tracking blood pressure to prevent kidney crisis, managing acid reflux to protect your lungs, and preventing Raynaud's attacks by staying warm and avoiding triggers.

Key Takeaways

  • • Regular pulmonary function tests and echocardiograms are essential to catch silent lung or heart changes early.
  • • Patients with diffuse scleroderma must monitor their blood pressure daily to quickly identify scleroderma renal crisis.
  • • Avoid cold medicines containing pseudoephedrine, as they constrict blood vessels and can trigger severe Raynaud's attacks.
  • • Taking prescribed proton pump inhibitors (PPIs) helps manage acid reflux and protects your lungs from micro-aspiration.
  • • Daily mouth stretching and the use of intensive, fragrance-free moisturizers help maintain skin mobility and comfort.

Scleroderma is a marathon, not a sprint. Because this is a chronic, systemic condition, staying healthy means shifting your focus from “crisis management” to “proactive surveillance.” By maintaining a rigorous monitoring schedule and mastering daily symptom management, you can stay ahead of the disease and maintain a high quality of life [1][2].

Your Long-Term Monitoring Calendar

Monitoring is necessary even when you feel well because internal organ changes—especially in the lungs and heart—can be “silent” in their early stages [3][4]. While your doctor will personalize this, a standard surveillance schedule often includes:

  • Pulmonary Function Tests (PFTs): Usually every 6 to 12 months. These tests (FVC and DLCO) are your “early warning system” for lung involvement [5][6].
  • Echocardiogram (Echo): Performed annually to screen for Pulmonary Arterial Hypertension (PAH), which is especially common in the limited (lcSSc) subtype [7][8].
  • High-Resolution CT (HRCT): All patients should have a baseline scan. Repeat scans are typically done every 1 to 2 years if there are changes in symptoms or PFT numbers [9].
  • Blood Pressure & Kidney Function: Routine labs (creatinine) and urine tests are essential to catch kidney changes early [10].

The Daily “Check”: Kidney Safety

For patients with Diffuse SSc (dcSSc) or those who test positive for Anti-RNA Polymerase III, daily monitoring is not just a suggestion—it is a critical safety measure.

  • The Goal: To catch Scleroderma Renal Crisis (SRC) before it causes damage. SRC is marked by a sudden, sharp rise in blood pressure [11][12].
  • The Threshold: Know your “normal” baseline. Generally, you should call your doctor or seek medical attention if your blood pressure jumps significantly—such as a rise of more than 20-30 points above your normal baseline, or if it suddenly reads higher than 140/90 along with a headache or visual changes [13][14].

Daily Management “Hacks”

Living with scleroderma requires specific strategies to manage the three most common daily challenges:

1. Managing Raynaud’s Phenomenon

  • Medication Danger: Check with your doctor or pharmacist before taking cold or sinus medications (like over-the-counter pseudoephedrine or decongestants) and certain prescription drugs (like beta-blockers). These restrict blood vessels and can cause a severe Raynaud’s attack or digital ulcers [15][16].
  • Stay Ahead of the Cold: Wear layers and use hand/toe warmers before you feel cold. Once an attack starts, it is much harder to stop [15].
  • Avoid Triggers: Smoking significantly worsens Raynaud’s and increases the risk of painful digital ulcers. Quitting is one of the best things you can do for your circulation [17][18].

2. Taming GERD (Reflux) and Fullness

Scleroderma reflux is caused by the esophagus becoming stiff and unable to clear acid properly [19][20].

  • Dietary Adjustments: Eat smaller, more frequent meals and chew your food extensively. This helps manage the feeling of getting full very quickly (early satiety) and reduces the strain on your digestive tract [21].
  • Mechanical Help: Elevate the head of your bed (not just your pillows) and avoid eating within 3 hours of bedtime [22].
  • Medication Consistency: Take your Proton Pump Inhibitors (PPIs) exactly as prescribed. In SSc, these medications do more than stop heartburn—they protect your lungs from inhaling micro-amounts of acid [23][24].

3. Maintaining Mobility (Skin & Joints)

  • Mouth Stretching: If your mouth opening is becoming smaller (microstomia), daily stretching exercises or specialized devices (like the Therabite) can help maintain your ability to eat and speak [25][26].
  • Skin Care: Use thick, fragrance-free moisturizers daily to help with the itching and tightness of the skin [25].

The Emotional Component

The “watchful waiting” of chronic monitoring can be exhausting. It is normal to feel “scanxiety” before tests. Connecting with peer support networks, such as the National Scleroderma Foundation or the Scleroderma Research Foundation, can give you community support and concrete starting points to manage the psychological toll of the diagnosis [27][28].

Frequently Asked Questions

How often should I have lung and heart tests for scleroderma?
You should typically have pulmonary function tests every 6 to 12 months and an echocardiogram annually. A high-resolution CT scan is also usually done at diagnosis and repeated every 1 to 2 years to catch any internal organ changes early.
Why do I need to monitor my blood pressure with scleroderma?
Daily blood pressure monitoring is critical, especially for diffuse scleroderma, to catch a severe complication called scleroderma renal crisis. A sudden spike in blood pressure, such as a rise of 20 to 30 points or a reading over 140/90, requires immediate medical attention.
What cold medications should I avoid if I have Raynaud's phenomenon?
You should avoid over-the-counter cold medicines and decongestants that contain pseudoephedrine. These medications restrict blood vessels and can trigger severe Raynaud's attacks or painful digital ulcers. Always check with your pharmacist before starting new medications.
How can I manage severe acid reflux caused by scleroderma?
Eat smaller, frequent meals, chew food thoroughly, and avoid eating within 3 hours of bedtime. Elevating the head of your bed and consistently taking prescribed proton pump inhibitors (PPIs) will help control stomach acid and protect your lungs from damage.
What can I do about mouth tightness from scleroderma?
If your mouth opening is becoming smaller, a condition called microstomia, daily stretching exercises can help. Specialized physical therapy devices can also assist in maintaining your range of motion so you can continue to eat and speak comfortably.

Questions for Your Doctor

  • • Based on my antibody profile (like Anti-RNA Polymerase III) and disease subtype, what is the exact frequency I should be checking my blood pressure at home?
  • • When is my next scheduled 'lung check' (PFTs and/or HRCT), and how often will we repeat these even if I feel fine?
  • • If my GERD symptoms are only partially responding to my current medication, should we consider adding a prokinetic or exploring a different type of acid blocker?
  • • Can you refer me to a physical or occupational therapist who specializes in scleroderma to help maintain my hand and mouth range of motion?
  • • What is the specific 'red flag' number for my blood pressure that should trigger an immediate call to your office?

Questions for You

  • • Are you keeping a log of your blood pressure readings, and do you know your personal 'baseline' (normal) reading?
  • • Have you noticed if specific temperatures or stressors trigger your Raynaud's more than others, and are you able to pre-heat your gloves or socks before exposure?
  • • Does your acid reflux wake you up at night, and have you tried elevating the head of your bed by 6 to 8 inches?
  • • How much is the constant need for monitoring affecting your stress levels, and do you have a support group or mental health resource to talk to?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Clinical features and prognostic factors of systemic sclerosis in Guangxi, China: Retrospective, single-center study of long-term survival in 470 patients.

    Chen J, Yang C, Pan J, et al.

    International journal of rheumatic diseases 2022; (25(2)):182-191 doi:10.1111/1756-185X.14261.

    PMID: 34889515
  2. 2

    Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.

    Ruaro B, Pizzorni C, Paolino S, et al.

    Microvascular research 2019; (125()):103874 doi:10.1016/j.mvr.2019.04.004.

    PMID: 30974112
  3. 3

    Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.

    Chong WH, Saha BK, Beegle S

    The American journal of the medical sciences 2023; (365(2)):198-204 doi:10.1016/j.amjms.2022.01.023.

    PMID: 35276077
  4. 4

    Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis.

    Bernstein EJ, Jaafar S, Assassi S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(11)):1892-1896 doi:10.1002/art.41415.

    PMID: 32583956
  5. 5

    Approach to interstitial lung disease associated with systemic sclerosis-A survey to pulmonologists and rheumatologists in Colombia.

    Galindo JL, García OM, Gil DR, et al.

    Reumatologia clinica 2024; (20(6)):334-340 doi:10.1016/j.reumae.2023.12.010.

    PMID: 38991827
  6. 6

    Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis.

    Repa A, Avgoustidis N, Kougkas N, et al.

    Mediterranean journal of rheumatology 2019; (30(1)):48-50 doi:10.31138/mjr.30.1.48.

    PMID: 32185343
  7. 7

    Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis.

    Callisto A, Hansen D, Walker J, et al.

    Arthritis care & research 2024; (76(1)):81-87 doi:10.1002/acr.25239.

    PMID: 37728139
  8. 8

    Reduced ventilatory efficiency during exercise predicts major vascular complications and mortality for interstitial lung disease in systemic sclerosis.

    Rosato E, Leodori G, Gigante A, et al.

    Clinical and experimental rheumatology 2020; (38 Suppl 125(3)):85-91.

    PMID: 32865173
  9. 9

    Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

    Khanna D, Distler O, Cottin V, et al.

    Journal of scleroderma and related disorders 2022; (7(3)):168-178 doi:10.1177/23971983211064463.

    PMID: 36211204
  10. 10

    [Renal Involvement in Connective Tissue Diseases].

    Weiner SM

    Deutsche medizinische Wochenschrift (1946) 2018; (143(2)):89-100 doi:10.1055/s-0043-106563.

    PMID: 29359289
  11. 11

    Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis.

    Elhannani A, Martel ME, Collet A, et al.

    Rheumatology (Oxford, England) 2025; (64(12)):6023-6035 doi:10.1093/rheumatology/keaf392.

    PMID: 40676730
  12. 12

    Kidney Transplantation in a Patient with Scleroderma.

    Bear L, Agmon Levine N, Ghinea R, et al.

    The Israel Medical Association journal : IMAJ 2024; (26(9)):593-595.

    PMID: 39397508
  13. 13

    Renal Involvement in Systemic Sclerosis: An Update.

    Chrabaszcz M, Małyszko J, Sikora M, et al.

    Kidney & blood pressure research 2020; (45(4)):532-548 doi:10.1159/000507886.

    PMID: 32521536
  14. 14

    Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

    Gordon SM, Stitt RS, Nee R, et al.

    The Journal of rheumatology 2019; (46(1)):85-92 doi:10.3899/jrheum.171186.

    PMID: 30008456
  15. 15

    The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study.

    Virgili-Gervais G, Matthews B, Nassar EL, et al.

    The Lancet. Rheumatology 2024; (6(10)):e684-e692 doi:10.1016/S2665-9913(24)00189-9.

    PMID: 39216493
  16. 16

    Update of EULAR recommendations for the treatment of systemic sclerosis.

    Kowal-Bielecka O, Fransen J, Avouac J, et al.

    Annals of the rheumatic diseases 2017; (76(8)):1327-1339 doi:10.1136/annrheumdis-2016-209909.

    PMID: 27941129
  17. 17

    Prevalence and severity of complicated Raynaud's phenomenon in limited and diffuse systemic sclerosis: a multicenter study in Iraq.

    Jaafar F, Moayad Z, Gorial F, Alkazzaz A

    Reumatologia 2025; (63(6)):383-388 doi:10.5114/reum/207625.

    PMID: 41583572
  18. 18

    The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.

    Silva C, Solanki KK, White DHN

    Rheumatology and immunology research 2022; (3(2)):84-89 doi:10.2478/rir-2022-0014.

    PMID: 36465326
  19. 19

    Esophageal manifestation in patients with scleroderma.

    Voulgaris TA, Karamanolis GP

    World journal of clinical cases 2021; (9(20)):5408-5419 doi:10.12998/wjcc.v9.i20.5408.

    PMID: 34307594
  20. 20

    Differentiating Delayed Esophageal Clearance From Reflux in Scleroderma.

    Pasumarthi A, Mago S, Banerjee P, Tadros M

    Cureus 2020; (12(11)):e11553 doi:10.7759/cureus.11553.

    PMID: 33365221
  21. 21

    Systemic Sclerosis, Malnutrition, and Small Bowel Obstruction: Why Clinicians Should Consider Early Total Parenteral Nutrition in Systemic Sclerosis With Severe Gastrointestinal Involvement.

    Massat B, McCarthy J

    Cureus 2022; (14(8)):e27638 doi:10.7759/cureus.27638.

    PMID: 36072159
  22. 22

    The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.

    Horsley-Silva JL, Umar SB, Vela MF, et al.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2019; (32(5)) doi:10.1093/dote/doy136.

    PMID: 30715227
  23. 23

    Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.

    Hughes M, Allanore Y, Baron M, et al.

    The Lancet. Rheumatology 2022; (4(11)):e795-e803 doi:10.1016/S2665-9913(22)00183-7.

    PMID: 37936680
  24. 24

    Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis.

    Kreuter M, Bonella F, Blank N, et al.

    Rheumatology (Oxford, England) 2023; (62(9)):3067-3074 doi:10.1093/rheumatology/kead023.

    PMID: 36708008
  25. 25

    Emerging treatments for scleroderma/systemic sclerosis.

    Zhu JL, Black SM, Chen HW, Jacobe HT

    Faculty reviews 2021; (10()):43 doi:10.12703/r/10-43.

    PMID: 34131653
  26. 26

    A mixed method study exploring patient satisfaction and feasibility of two exercise programmes in systemic sclerosis-associated microstomia.

    Sydow E, Van der Elst K, Verschueren P, et al.

    Rheumatology advances in practice 2021; (5(2)):rkab017 doi:10.1093/rap/rkab017.

    PMID: 34013159
  27. 27

    Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire.

    Benmostefa N, Malek R, Robert M, et al.

    Journal of scleroderma and related disorders 2024; (9(2)):134-142 doi:10.1177/23971983241231082.

    PMID: 38910602
  28. 28

    Patient perception of disease burden in diffuse cutaneous systemic sclerosis.

    Khanna D, Allanore Y, Denton CP, et al.

    Journal of scleroderma and related disorders 2020; (5(1)):66-76 doi:10.1177/2397198319866615.

    PMID: 35382406

This page provides educational information about managing scleroderma daily life and monitoring. It does not replace professional medical advice. Always consult your rheumatologist about your specific symptoms and monitoring schedule.

Stay up to date

Get notified when new research about Scleroderma is published.

No spam. Unsubscribe anytime.